Overview

Influenza Vaccine To Prevent Adverse Vascular Events:Pilot

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

A multi-centre, randomized, placebo controlled, trial. Participants at high-risk for vascular events from the network of INTER- CHF will be randomized to inactivated influenza vaccine or placebo and followed prospectively over three influenza seasons. 600 participants will be enrolled prior to influenza season and randomized to either influenza vaccine or saline placebo.

Phase:

Phase 4

Details

Lead Sponsor:

McMaster University

Collaborator:

Population Health Research Institute

Treatments:

Vaccines